2- Hepatic/liver Disease Flashcards
An AST/ ALT > 1.5 (but traditionally ≥ 2) indicates what condition?
Alcoholic liver disease
An AST/ ALT < 1.0 indicates what condition?
NASH (often acute or chonic viral hepatitis)
An AST/ ALT > 10 indicates what condition?
Cirrhosis
An ALT/ AST < 1.0 indicates what condition?
Fatty liver
What conditions are indicative of low to high ALT values? (ranging from ~40 to 10,000)
Hepatitis B + C chronic → EtOH → Hepatitis C, A + B acute → “shock liver” or acetaminophen toxicity
What is defined as inflammation of the liver by fat deposition?
Steatohepatitis
Predominantly elevated ALT and AST (liver transaminases) indicate what?
Hepatocellular pattern
What is the spectrum of diseases included as part of NAFLD (non- alcoholic fatty liver disease)?
NAFL → NASH → NASH cirrhosis
How is NAFL (aka isolated steatosis) defined?
Fatty liver without injury or fibrosis of hepatocytes on bx
How is NASH defined?
Fatty liver + inflammation = hepatocyte injury
Risk of progression of fibrosis, cirrhosis is significant
The following are RFs for what condition?
Abd obesity, DMT2, hyperlipidemia, metabolic syndrome, PCOS
NAFLD
(metabolic syndrome = strongest predictor)
How does NAFLD typically present clinically?
Asx, often incidental finding
What tools are used to aid in identifying those with NAFLD that are at risk for advanced fibrosis?
NAFLD fibrosis score, fibrosis-4 index, vibration-controlled transient elastography (VCTE)
On fibroscan (VCTE) you note ≥ 5% liver fat on imaging or liver bx, US notes fat present on the liver, labs show hepatocellular pattern with elevated ferritin, lipids, and glucose. What are you concerned for?
NAFLD
When is it recommended to obtain a liver biopsy in pts with NAFLD?
Increased risk for advanced fibrosis, metabolic syndrome/ elevated LFTs, need to r/o competing etiologies
What conditions must be r/o when evaluating suspected NAFLD?
Significant alcohol consumption, competing etiologies for hepatic steatosis, coexisting causes of chronic liver disease (CLD)
Pts with NAFLD are at a high risk for what?
CV morbidity/ mortality
(aggressive modification of CVD RFs should be considered)
What is used in the treatment of dyslipidemia in patients with NAFLD and NASH, and when should this treatment be avoided?
Statins; avoided in pts with decompensated cirrhosis
What is considered the “cornerstone” of NASH management?
Exercise and weight loss
(should also minimize EtOH, control underlying conditions, vaccinate)
What is the relationship between body weight reduction and histological improvement of NASH?
>3% improves steatosis
7-10% NASH resolution
≥10% fibrosis regression
What are the hereditary liver disorders? (3)
Hereditary hemochromatosis, alpha-1 antitrypsin deficiency, Wilson’s disease
What is hereditary hemochromatosis?
Hereditary disorder of iron metabolism
What is the pathophysiology of hereditary hemochromatosis?
Genetic mutation → increased GI absorption of iron → accumulation of iron in tissues
(liver, pancreas, heart, adrenals, testes, pituitary, skin, kidney)
How does hereditary hemochromatosis present clinically (early stages)?
FH or incidentally noted increased AST and ALT
Initially non-specific sxs (fatigue, malaise, RUQ discomfort)